60 related articles for article (PubMed ID: 11433379)
1. Structural and functional dissection of the cytoplasmic domain of the transmembrane adaptor protein SIT (SHP2-interacting transmembrane adaptor protein).
Pfrepper KI; Marie-Cardine A; Simeoni L; Kuramitsu Y; Leo A; Spicka J; Hilgert I; Scherer J; Schraven B
Eur J Immunol; 2001 Jun; 31(6):1825-36. PubMed ID: 11433379
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphorylation sites on FRS2alpha responsible for Shp2 recruitment are critical for induction of lens and retina.
Gotoh N; Ito M; Yamamoto S; Yoshino I; Song N; Wang Y; Lax I; Schlessinger J; Shibuya M; Lang RA
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17144-9. PubMed ID: 15569927
[TBL] [Abstract][Full Text] [Related]
3. H-2Dd engagement of Ly49A leads directly to Ly49A phosphorylation and recruitment of SHP1.
Daws MR; Eriksson M; Oberg L; Ullén A; Sentman CL
Immunology; 1999 Aug; 97(4):656-64. PubMed ID: 10457220
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor receptor 1 (FGFR1) tyrosine phosphorylation regulates binding of FGFR substrate 2alpha (FRS2alpha) but not FRS2 to the receptor.
Zhang Y; McKeehan K; Lin Y; Zhang J; Wang F
Mol Endocrinol; 2008 Jan; 22(1):167-75. PubMed ID: 17901128
[TBL] [Abstract][Full Text] [Related]
5. Probing the Immunoreceptor Tyrosine-Based Inhibition Motif Interaction Protein Partners with Proteomics.
Gao Y; Xing S; Hu L
Molecules; 2024 Apr; 29(9):. PubMed ID: 38731468
[TBL] [Abstract][Full Text] [Related]
6. UNC-51-like kinase regulation of fibroblast growth factor receptor substrate 2/3.
Avery AW; Figueroa C; Vojtek AB
Cell Signal; 2007 Jan; 19(1):177-84. PubMed ID: 16887332
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of SH2D4A, a novel adapter protein related to T cell-specific adapter and adapter protein in lymphocytes of unknown function, reveals a redundant function in T cells.
Lapinski PE; Oliver JA; Kamen LA; Hughes ED; Saunders TL; King PD
J Immunol; 2008 Aug; 181(3):2019-27. PubMed ID: 18641339
[TBL] [Abstract][Full Text] [Related]
8. The role of adapter proteins in T cell activation.
Koretzky GA; Boerth NJ
Cell Mol Life Sci; 1999 Dec; 56(11-12):1048-60. PubMed ID: 11212321
[TBL] [Abstract][Full Text] [Related]
9. The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain.
van Vlimmeren AE; Voleti R; Chartier CA; Jiang Z; Karandur D; Humphries PA; Lo WL; Shah NH
bioRxiv; 2024 Apr; ():. PubMed ID: 37502916
[TBL] [Abstract][Full Text] [Related]
10. Phosphopeptide binding to the N-SH2 domain of tyrosine phosphatase SHP2 correlates with the unzipping of its central β-sheet.
Marasco M; Kirkpatrick J; Carlomagno T; Hub JS; Anselmi M
Comput Struct Biotechnol J; 2024 Dec; 23():1169-1180. PubMed ID: 38510972
[TBL] [Abstract][Full Text] [Related]
11. Determination of promising inhibitors for N-SH2 domain of SHP2 tyrosine phosphatase: an in silico study.
Gencer Akçok EB; Güner H; Akçok İ
Mol Divers; 2024 May; ():. PubMed ID: 38739228
[TBL] [Abstract][Full Text] [Related]
12. A high-throughput two-cell assay for interrogating inhibitory signaling pathways in T cells.
Sharma S; Whitehead T; Kotowski M; Ng EZQ; Clarke J; Leitner J; Chen YL; Santos AM; Steinberger P; Davis SJ
Life Sci Alliance; 2024 Mar; 7(3):. PubMed ID: 38073578
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the avian Trojan gene family reveals contrasting evolutionary constraints.
Petrov P; Syrjänen R; Smith J; Gutowska MW; Uchida T; Vainio O; Burt DW
PLoS One; 2015; 10(3):e0121672. PubMed ID: 25803627
[TBL] [Abstract][Full Text] [Related]
14. TULA-family proteins: an odd couple.
Tsygankov AY
Cell Mol Life Sci; 2009 Sep; 66(17):2949-52. PubMed ID: 19585081
[TBL] [Abstract][Full Text] [Related]
15. Lymphoma immunotherapy: the garden of forking paths.
Ang Z; Thomas-Tikhonenko A
Blood; 2024 Feb; 143(8):655-657. PubMed ID: 38386427
[No Abstract] [Full Text] [Related]
16. SIT1 identifies circulating hypoactive T cells with elevated cytotoxic molecule secretion in systemic lupus erythematosus patients.
Hasimu A; Bahabayi A; Xiong Z; Li Q; Zhang Z; Zeng X; Zheng M; Yuan Z; Liu C
Immunol Res; 2024 May; ():. PubMed ID: 38691318
[TBL] [Abstract][Full Text] [Related]
17. CSK-mediated signalling by integrins in cancer.
Maldonado H; Leyton L
Front Cell Dev Biol; 2023; 11():1214787. PubMed ID: 37519303
[TBL] [Abstract][Full Text] [Related]
18. Discovery and Validation of a SIT1-Related Prognostic Signature Associated with Immune Infiltration in Cutaneous Melanoma.
Jia M; Liu C; Liu Y; Bao Z; Jiang Y; Sun X
J Pers Med; 2022 Dec; 13(1):. PubMed ID: 36675674
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive review of SHP2 and its role in cancer.
Asmamaw MD; Shi XJ; Zhang LR; Liu HM
Cell Oncol (Dordr); 2022 Oct; 45(5):729-753. PubMed ID: 36066752
[TBL] [Abstract][Full Text] [Related]
20. T cell receptor (TCR) signaling in health and disease.
Shah K; Al-Haidari A; Sun J; Kazi JU
Signal Transduct Target Ther; 2021 Dec; 6(1):412. PubMed ID: 34897277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
